Published in Gastroenterology on April 01, 2000
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg (2003) 2.03
Proton pump inhibitors and gastric neoplasia. Gut (2006) 1.90
Gastro-oesophageal reflux disease. BMJ (2006) 1.81
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut (2006) 1.67
Safety of the long-term use of proton pump inhibitors. World J Gastroenterol (2010) 1.55
Long-term proton pump inhibitor use in children: a retrospective review of safety. Dig Dis Sci (2007) 1.49
Management of gastro-oesophageal reflux disease in general practice. BMJ (2001) 1.48
Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci (2011) 1.43
Mortality study of 18 000 patients treated with omeprazole. Gut (2003) 1.39
Long term failure of endoscopic gastroplication (EndoCinch). Gut (2005) 1.38
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut (2003) 1.26
Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol (2009) 1.12
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06
Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci (2008) 1.04
Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol (2004) 1.03
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Ann Surg (2001) 1.02
The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg (2007) 1.00
Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol (2010) 0.98
Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol (2008) 0.97
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep (2015) 0.96
Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results. Surg Endosc (2009) 0.96
Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol (2012) 0.95
Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child (2005) 0.93
Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials. Can J Gastroenterol (2008) 0.93
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer (2009) 0.93
Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer (2011) 0.91
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc (2012) 0.91
Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch (2004) 0.90
Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies. World J Gastroenterol (2013) 0.90
Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia. Dig Dis Sci (2012) 0.87
Diagnosis and management of gastroesophageal reflux disease. Arq Bras Cir Dig (2014) 0.86
Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. Ann Surg (2002) 0.86
Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig Dis Sci (2006) 0.85
The management of postoperative reflux in congenital esophageal atresia-tracheoesophageal fistula: a systematic review. Pediatr Surg Int (2014) 0.85
Treatment of uncomplicated reflux disease. World J Gastroenterol (2005) 0.85
The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology (2000) 0.84
Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells. Ann Gastroenterol (2012) 0.81
Gastroesophageal reflux disease: medical or surgical treatment? Gastroenterol Res Pract (2009) 0.81
Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist. Gut (2002) 0.81
Barrett's Esophagus, a Complication of GERD. Curr Treat Options Gastroenterol (2002) 0.80
Does laparoscopic Nissen fundoplication prevent the progression of Barrett's oesophagus? Is the length of Barrett's a factor? J Minim Access Surg (2005) 0.80
Quality of life before and after laparoscopic Nissen fundoplication. Surg Endosc (2001) 0.79
Recent advances in noncardiac chest pain in Korea. Gut Liver (2012) 0.79
Management strategies of Barrett's esophagus. World J Gastroenterol (2012) 0.79
Does gastric atrophy exist in children? World J Gastroenterol (2006) 0.79
Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World J Gastroenterol (2005) 0.77
Long-term omeprazole treatment and fundic gland polyps: a very authoritative proof against a link? Am J Gastroenterol (2001) 0.77
Barrett's esophagus without esophageal stricture does not increase the rate of failure of Nissen fundoplication. Ann Surg (2003) 0.77
Does the learning phase influence the late outcome of patients with gastroesophageal reflux disease after laparoscopic fundoplication? Surg Endosc (2003) 0.77
Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan. World J Gastroenterol (2011) 0.77
Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms? World J Surg Oncol (2014) 0.76
Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis. Gastroenterol Res Pract (2013) 0.76
Pharmacologic Management of Gastroesophageal Reflux Disease. Curr Treat Options Gastroenterol (2002) 0.76
Mechanism of acid hypersecretion post curative gastrinoma resection. Dig Dis Sci (2010) 0.76
Comparison of esomeprazole enteric-coated capsules vs esomeprazole magnesium in the treatment of active duodenal ulcer: a randomized, double-blind, controlled study. World J Gastroenterol (2008) 0.75
Long-term effects of omeprazole on the gastric mucosa. Gastroenterology (2000) 0.75
Long-term omeprazole treatment and risk of gastric cancer. Gastroenterology (2000) 0.75
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole. Ther Clin Risk Manag (2010) 0.75
Hydrogen and methane gases are frequently detected in the stomach. World J Gastroenterol (2006) 0.75
Efficacy and safety of long-term omeprazole treatment. Gastroenterology (2000) 0.75
A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life. Curr Ther Res Clin Exp (2016) 0.75
Endoscopic antireflux therapy. Surg Endosc (2003) 0.75
Long-term experience of treating 185 patients with gastroesophageal reflux disease (GERD) by anti-reflux surgery respecting the functional-morphological restoration of the esophagus. Langenbecks Arch Surg (2005) 0.75
Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis. Saudi J Gastroenterol (2017) 0.75
The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study. Surg Endosc (2008) 0.75
Gastric fundal polyps with cellular atypia in a patient using esomeprazole (Nexium). Dig Dis Sci (2005) 0.75
Nilotinib Induced Recurrent Gastric Polyps: Case Report and Review of Literature. Am J Case Rep (2017) 0.75
Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother (1983) 8.82
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest (1980) 5.11
Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med (1982) 5.07
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology (1999) 4.41
The pharmacokinetics and tissue penetration of ofloxacin. J Antimicrob Chemother (1984) 4.15
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med (1996) 4.11
Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med (1994) 4.00
Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut (2004) 3.85
Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet (1978) 3.69
Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet (1976) 3.61
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology (2000) 3.58
Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology (1988) 3.51
A new technique for continuous sphincter pressure measurement. Gastroenterology (1976) 3.44
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04
Transient lower esophageal sphincter relaxation. Gastroenterology (1995) 2.91
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet (2001) 2.88
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.85
Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob Agents Chemother (1984) 2.83
Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J (Clin Res Ed) (1982) 2.80
Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother (1984) 2.79
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg (2007) 2.66
Pathogenesis of reflux esophagitis. Gastroenterology (1981) 2.58
Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology (1995) 2.53
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
The Scottish doctor--learning outcomes for the medical undergraduate in Scotland: a foundation for competent and reflective practitioners. Med Teach (2002) 2.43
The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography. Neurogastroenterol Motil (2009) 2.34
Dose of inhaled budesonide required to produce clinical suppression of plasma cortisol. Eur J Respir Dis (1987) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Toxicological studies on omeprazole. Scand J Gastroenterol Suppl (1985) 2.19
Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med (2000) 2.14
Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. Gastroenterology (1995) 2.12
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Behavior and gastroesophageal reflux in the premature neonate. J Pediatr Gastroenterol Nutr (2000) 2.07
Hydatidiform mole in England and Wales 1973-83. Lancet (1986) 2.05
Aspirin and bleeding peptic ulcers in the elderly. BMJ (1988) 2.00
Subcellular fractionation of aerobically grown Saccharomyces carlsbergensis by zonal centrifugation. Biochem J (1970) 1.98
Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.95
Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group. Gastroenterology (1994) 1.94
Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91
Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol (1988) 1.89
Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology (2000) 1.86
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Intraoperative air testing of colorectal anastomoses: a prospective, randomized trial. Br J Surg (1990) 1.79
Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology (1985) 1.75
Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut (2000) 1.74
Origin of spiral organisms in human gastric antrum. Lancet (1988) 1.72
Upper esophageal sphincter function during deglutition. Gastroenterology (1988) 1.71
Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut (1996) 1.71
Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology (1997) 1.70
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69
Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology (1986) 1.66
Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion? Aliment Pharmacol Ther (2000) 1.65
Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein. Mol Cell Biol (1989) 1.62
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology (1997) 1.62
Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61
Branchial cleft cysts, sinuses, and fistulas. Otolaryngol Clin North Am (1981) 1.60
The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol (1979) 1.59
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
The effect of oxygen on denitrification in Paracoccus denitrificans and Pseudomonas aeruginosa. J Gen Microbiol (1989) 1.58
Factors affecting the onset of ventricular fibrillation in hypothermia. Lancet (1974) 1.58
Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. J Microsc (1994) 1.58
The ability of membrane potential dyes and calcafluor white to distinguish between viable and non-viable bacteria. J Appl Bacteriol (1995) 1.57
Motor activity of the gastric antrum, pylorus, and duodenum under fasted conditions and after a liquid meal. Gastroenterology (1988) 1.57
Students validate problem based learning. BMJ (2006) 1.56
Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion (1986) 1.56
Control of belching by the lower oesophageal sphincter. Gut (1990) 1.54
Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire. Anaesthesia (1997) 1.53
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Upper esophageal sphincter function during belching. Gastroenterology (1986) 1.50
Changes in quality of life after intensive care: comparison with normal data. Anaesthesia (1997) 1.50
A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients. Gastrointest Endosc (1999) 1.50
Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology (1988) 1.50
Anoxic function for the Escherichia coli flavohaemoglobin (Hmp): reversible binding of nitric oxide and reduction to nitrous oxide. FEBS Lett (1999) 1.49
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut (1999) 1.49
Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog. Gastroenterology (1986) 1.49
Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust (1992) 1.48
Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J (2000) 1.46
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg (1987) 1.45
Stimulation of pyloric motility by intraduodenal dextrose in normal subjects. Gut (1988) 1.44
Human duodenal phase III migrating motor complex activity is predominantly antegrade, as revealed by high-resolution manometry and colour pressure plots. Neurogastroenterol Motil (2002) 1.44
Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol (1984) 1.44
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol (1997) 1.44
Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol (1994) 1.43
The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid. J Antimicrob Chemother (1984) 1.43
Molecular data suggest an early acquisition of the mitochondrion endosymbiont. Proc Biol Sci (1996) 1.43
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology (1983) 1.43
Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med (1985) 1.41
Follow-up of Helicobacter pylori positive gastritis and argyrophil cells pattern during the natural course of gastric ulcer. Helicobacter (1998) 1.41
Propionate assimilation in the flagellate Polytomella caeca. An inducible mitochondrial enzyme system. Biochem J (1968) 1.41
Properties of mitochondria isolated from cyanide-sensitive and cyanide-stimulated cultures of Acanthamoeba castellanii. Biochem J (1978) 1.41
Wales is not part of England! Science (2002) 1.40